| Category | Peptides vs small molecules | Peptides vs biomolecules |
|---|---|---|
| Disadvantages |
|
|
| Advantages |
|
|
| Category | Peptides vs small molecules | Peptides vs biomolecules |
|---|---|---|
| Disadvantages |
|
|
| Advantages |
|
|
The authors thank all the students who were part of this journey and who have supported each of the reported publications.
CC: Conceptualization, Data Curation, Writing—original draft, Writing—review & editing, Validation, Visualization, Funding acquisition. PS: Writing—review & editing. CA: Data curation, Writing—original draft, Writing—review & editing, Validation. LM and SM: Writing—review & editing. FA: Writing—review & editing, Validation. FG: Conceptualization, Data curation, Validation, Project administration.
Fernando Albericio, the Editor-in-Chief and a Guest Editor of Exploration of Drug Science, and Fanny Guzmán, a Guest Editor of Exploration of Drug Science, had no involvement in the decision-making or the review process of this manuscript. The other authors declare no conflicts of interest.
Not applicable.
Not applicable.
Not applicable.
Not applicable.
FG received financial support from ANID Fondecyt [1210056]. CC received funding support form ANID Fondecyt [1240448]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
© The Author(s) 2024.